Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

Cited by (1,040)

Items 601–700 of 1,040

  1. Structure-based design of conformation- and sequence-specific antibodies against amyloid β
    Joseph M. Perchiacca, Ali Reza A. Ladiwala, Moumita Bhattacharya, Peter M. Tessier · 2011 · Proceedings of the National Academy of Sciences
  2. Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor
    Roni Scherzer‐Attali, Riccardo Pellarin, Marino Convertino, Anat Frydman‐Marom, Nirit Egoz-Matia, Sivan Peled, Michal Levy‐Sakin, Deborah E. Shalev, Amedeo Caflisch, Ehud Gazit et al. · 2010 · PLoS ONE
  3. Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer’s disease
    Laura T. Haas, Santiago V. Salazar, Mikhail A. Kostylev, Ji Won Um, Adam C. Kaufman, Stephen M. Strittmatter · 2015 · Brain
  4. The Alzheimer Disease Protective Mutation A2T Modulates Kinetic and Thermodynamic Properties of Amyloid-β (Aβ) Aggregation
    Iryna Benilova, Rodrigo U. Gallardo, Andreea-Alexandra Ungureanu, Virginia Castillo Cano, An Snellinx, Meine Ramakers, Carmen Bartic, Frédéric Rousseau, Joost W. H. Schymkowitz, Bart De Strooper · 2014 · Journal of Biological Chemistry
  5. Cognitive‐Performance Recovery of Alzheimer's Disease Model Mice by Modulation of Early Soluble Amyloidal Assemblies
    Anat Frydman‐Marom, Meirav Rechter, Irit Shefler, Yaron Bram, Deborah E. Shalev, Ehud Gazit · 2008 · Angewandte Chemie International Edition
  6. Fucoxanthin Inhibits β-Amyloid Assembly and Attenuates β-Amyloid Oligomer-Induced Cognitive Impairments
    Siying Xiang, Fufeng Liu, Jiajia Lin, Huixin Chen, Chunhui Huang, Liping Chen, Yiying Zhou, Luying Ye, Ke Zhang, Jiukai Jin et al. · 2017 · Journal of Agricultural and Food Chemistry
  7. Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method
    Francesco A. Aprile, Pietro Sormanni, Michele Perni, Paolo Arosio, Sara Snogerup Linse, Tuomas P. J. Knowles, Christopher Martin Dobson, Michele Vendruscolo · 2017 · Science Advances
  8. Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid‐β peptide
    Eva Y. Chi, Canay Ege, Amy Winans, Jaroslaw P. Majewski, Guohui Wu, Kristian Kjær, Ka Yee C. Lee · 2008 · Proteins Structure Function and Bioinformatics
  9. Inhibiting, promoting, and preserving stability of functional proteinfibrils
    Owen G. Jones, Raffaele Mezzenga · 2011 · Soft Matter
  10. Oxidative Metabolites Accelerate Alzheimer's Amyloidogenesis by a Two-Step Mechanism, Eliminating the Requirement for Nucleation
    Jan Bieschke, Qinghai Zhang, Evan T. Powers, Richard Alan Lerner, Jeffery W. Kelly · 2005 · Biochemistry
  11. IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1–42 by Rat Primary Type 2 Microglia
    Shimizu, Eisuke, Kawahara, Kohichi, Kajizono, Makoto, Sawada, Makoto, Nakayama, Hitoshi · 2008 · The Journal of Immunology
  12. Mechanisms of Transthyretin Inhibition of β-Amyloid AggregationIn Vitro
    Xinyi Li, Xin Zhang, Ali Reza A. Ladiwala, Deguo Du, Jay Kant Yadav, Peter M. Tessier, Peter E. Wright, Jeffery W. Kelly, Joel N. Buxbaum · 2013 · Journal of Neuroscience
  13. Amyloid Protofibrils of Lysozyme Nucleate and Grow Via Oligomer Fusion
    Shannon E. Hill, Joshua Robinson, Garrett Matthews, Martin Muschol · 2009 · Biophysical Journal
  14. Protein Microgels from Amyloid Fibril Networks
    Ulyana Shimanovich, Igor Efimov, Thomas G. Mason, Patrick Flagmeier, Alexander Kai Buell, Aharon Gedanken, Sara Snogerup Linse, Karin S. Åkerfeldt, Christopher Martin Dobson, David A. Weitz et al. · 2014 · ACS Nano
  15. Peptide‐Based Molecular Strategies To Interfere with Protein Misfolding, Aggregation, and Cell Degeneration
    Valentina Armiento, Anna Spanopoulou, Aphrodite Kapurniotu · 2019 · Angewandte Chemie International Edition
  16. Role of islet amyloid in type 2 diabetes mellitus
    Jo W.M. Höppener, C.J.M. Lips · 2006 · The International Journal of Biochemistry & Cell Biology
  17. Shedding of soluble platelet-derived growth factor receptor-β from human brain pericytes
    Sagare, Abhay P., Sweeney, Melanie D., Makshanoff, Jacob, Zlokovic, Berislav V. · 2015 · Neuroscience Letters
  18. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
    Nishant N. Vaikath, Nour K. Majbour, Katerina E. Paleologou, Mustafa Taleb Ardah, Esther van Dam, Wilma D. J. van de Berg, Shelley L. Forrest, Laura Parkkinen, Wei‐Ping Gai, Nobutaka Hattori et al. · 2015 · Neurobiology of Disease
  19. Adiponectin is Protective against Oxidative Stress Induced Cytotoxicity in Amyloid-Beta Neurotoxicity
    Koon‐Ho Chan, Karen S.L. Lam, On-Yin Cheng, Jason Kwan, Philip Wing‐Lok Ho, Kenneth K.Y. Cheng, Sookja Kim Chung, Jessica Wing-Man Ho, Vivian Yawei Guo, Almin Xu · 2012 · PLoS ONE
  20. Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective
    Paul J. Derry, Muralidhar L. Hegde, George R. Jackson, Rakez Kayed, James M. Tour, Ah-Lim Tsai, Thomas A. Kent · 2019 · Progress in Neurobiology
  21. Self Assembly of Short Aromatic Peptides into Amyloid Fibrils and Related Nanostructures
    Ehud Gazit · 2007 · Prion
  22. β-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes
    Aleksey V. Matveyenko, Peter C. Butler · 2006 · Diabetes
  23. Brain Injection of α-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker
    Sacino, Amanda N., Brooks, Mieu, McKinney, Alex B., Thomas, Michael A., Shaw, Gerry, Golde, Todd E., Giasson, Benoit I. · 2014 · The Journal of Neuroscience
  24. Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases
    Agnès Rioux Bilan, Aline Freyssin, Guylène Page, Bernard Fauconneau · 2018 · Neural Regeneration Research
  25. Formation and physicochemical properties of amyloid fibrils from soy protein
    Yajuan Wang, Yanting Shen, Guangyan Qi, Ya Li, Xiuzhi Susan Sun, Dan Qiu, Yonghui Li · 2020 · International Journal of Biological Macromolecules
  26. Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies
    William J. Wolfgang, Todd W. Miller, Jack M. Webster, James S. Huston, Leslie Michels Thompson, Joan Marsh, Anne C. Messer · 2005 · Proceedings of the National Academy of Sciences
  27. Branched KLVFF Tetramers Strongly Potentiate Inhibition of β‐Amyloid Aggregation
    Sidhartha M. Chafekar, Hinke Malda, Maarten Merkx, Egbert W. Meijer, David Viertl, Hilal Ahmed Lashuel, Frank Baas, Wiep Scheper · 2007 · ChemBioChem
  28. Mechanisms of protein toxicity in neurodegenerative diseases
    Chung, Chang Geon, Lee, Hyosang, Lee, Sung Bae · 2018 · Cellular and Molecular Life Sciences
  29. Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β
    Rudy J. Castellani, Hyoung‐gon Lee, Sandra L. Siedlak, Akihiko Nunomura, Takaaki Hayashi, Masao Nakamura, Xiongwei Zhu, George L. Perry, Mark A. Smith · 2009 · Journal of Alzheimer s Disease
  30. Cardiomyocyte Expression of a Polyglutamine Preamyloid Oligomer Causes Heart Failure
    J. Scott Pattison, Atsushi Sanbe, Alina Maloyan, Hanna E. Osińska, Raisa Klevitsky, Jeffrey M. Robbins · 2008 · Circulation
  31. Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity
    van Ham, Tjakko J., Holmberg, Mats A., van der Goot, Annemieke T., Teuling, Eva, Garcia-Arencibia, Moises, Kim, Hyun-eui, Du, Deguo, Thijssen, Karen L., Wiersma, Marit, Burggraaff, Rogier et al. · 2010 · Cell
  32. Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
    Ming‐Che Lee, Wancheng Yu, Yao‐Hsiang Shih, Chun‐Yu Chen, Zhong‐Hong Guo, Shing‐Jong Huang, Jerry C. C. Chan, Yun‐Ru Chen · 2018 · Scientific Reports
  33. Protein Aggregates and Novel Presenilin Gene Variants in Idiopathic Dilated Cardiomyopathy
    Davide Gianni, Airong Li, Giuseppina Tesco, Kenneth Matthew McKay, John Moore, Kunal P. Raygor, Marcello Rota, Judith K. Gwathmey, G. WILLIAM DEC, Thomas Aretz et al. · 2010 · Circulation
  34. Prion recognition elements govern nucleation, strain specificity and species barriers
    Peter M. Tessier, Susan Lee Lindquist · 2007 · Nature
  35. A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114
    Adam Crystal, Benoit I. Giasson, Alex Crowe, Mei‐Ping Kung, Zhi‐Ping Zhuang, John Q. Trojanowski, Virginia M.‐Y. Lee · 2003 · Journal of Neurochemistry
  36. One‐compound‐multiple‐targets strategy to combat Alzheimer's disease
    Hongyu Zhang · 2005 · FEBS Letters
  37. Niemann-Pick Type C Disease and Alzheimer's Disease
    Ralph A. Nixon · 2004 · American Journal Of Pathology
  38. Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer’s disease
    Bobkova, Natalia V., Garbuz, David G., Nesterova, Inna, Medvinskaya, Natalia, Samokhin, Alexander, Alexandrova, Irina, Yashin, Valerii, Karpov, Vadim, Kukharsky, Michail S., Ninkina, Natalia N. et al. · 2013 · Journal of Alzheimer's Disease
  39. Why is the amyloid beta peptide of Alzheimer’s disease neurotoxic?
    Rauk, Arvi · 2008 · Dalton Transactions
  40. Glial cell dysregulation: a new perspective on Alzheimer disease
    Rommy von Bernhardi M. · 2007 · Neurotoxicity Research
  41. Induction of endoplasmic reticulum stress-induced β-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide
    Chang-jiang Huang, Leena Haataja, Tatyana Gurlo, Alexandra E. Butler, Xiuju Wu, Walter C. Soeller, Peter C. Butler · 2007 · American Journal of Physiology-Endocrinology and Metabolism
  42. Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimers Disease
    Francesca Re, Cristina Airoldi, Cristiano Zona, Massimo Masserini, Barbara La Ferla, N. Quattrocchi, Francesco Nicotra · 2010 · Current Medicinal Chemistry
  43. Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease
    Jiankang Liu, Bruce N. Ames · 2005 · Nutritional Neuroscience
  44. Pauling and Corey's α-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease
    Roger S. Armen, Mari L. DeMarco, Darwin O. V. Alonso, Valerie Daggett · 2004 · Proceedings of the National Academy of Sciences
  45. Noninvasive 40-hz light flicker to recruit microglia and reduce amyloid beta load
    Singer, Annabelle C., Martorell, Anthony J., Douglas, J. Miller, Abdurrob, Fatema, Attokaren, Matthew K., Tipton, John, Mathys, Hansruedi, Adaikkan, Chinnakkaruppan, Tsai, Li-Huei · 2018 · Nature Protocols
  46. Cytotoxicity of Intracellular Aβ 42 Amyloid Oligomers Involves Ca 2+ Release from the Endoplasmic Reticulum by Stimulated Production of Inositol Trisphosphate
    Angelo Demuro, Ian Parker · 2013 · Journal of Neuroscience
  47. Polyglutamine diseases: The special case of ataxin-3 and Machado–Joseph disease
    Carlos A. Matos, Sandra Macedo‐Ribeiro, Ana Luı́sa Carvalho · 2011 · Progress in Neurobiology
  48. Differential effects of glycation on protein aggregation and amyloid formation
    Clara Iannuzzi, Gaetano Irace, Ivana Sirangelo · 2014 · Frontiers in Molecular Biosciences
  49. Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition
    Frank Gillardon, Wolfgang Rist, Lothar Kußmaul, Johannes Vogel, Matthias Berg, Karin M. Danzer, Norbert Kraut, Bastian Hengerer · 2007 · PROTEOMICS
  50. Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson’s Disease
    Giorgio Vivacqua, Anna Latorre, Antonio Suppa, Michela Nardi, Sara Pietracupa, Romina Mancinelli, Giovanni Fabbrini, Carlo Colosimo, Eugenio Gaudio, Alfredo Berardelli · 2016 · PLoS ONE
  51. Oligemic Hypoperfusion Differentially Affects Tau and Amyloid-β
    Koike, Maya A., Green, Kim N., Blurton-Jones, Mathew, LaFerla, Frank M. · 2010 · The American Journal of Pathology
  52. Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain
    Cristian A. Lasagna‐Reeves, Charles G. Glabe, Rakez Kayed · 2011 · Journal of Biological Chemistry
  53. Strategies for the Inhibition of Protein Aggregation in Human Diseases
    Manuela Bartolini, Vincenza Andrisano · 2010 · ChemBioChem
  54. Effect of β-sheet propensity on peptide aggregation
    Giovanni Bellesia, Joan‐Emma Shea · 2009 · The Journal of Chemical Physics
  55. Amyloid precursor protein and amyloid β-peptide bind to ATP synthase and regulate its activity at the surface of neural cells
    Carsten Schmidt, E Lepsverdize, S L, Anibh Martin Das, Salvatore Vincent Pizzo, Alexander E. Dityatev, Melitta Schachner · 2007 · Molecular Psychiatry
  56. The Polyphenol EGCG Inhibits Amyloid Formation Less Efficiently at Phospholipid Interfaces than in Bulk Solution
    Maarten F. M. Engel, Corianne C. vandenAkker, Michael Schleeger, Krassimir P. Velikov, Gijsje Hendrika Koenderink, Mischa Bonn · 2012 · Journal of the American Chemical Society
  57. Disease-associated amyloid and misfolded protein aggregates activate the inflammasome
    Seth Lucian Masters, Luke A.J. O'Neill · 2011 · Trends in Molecular Medicine
  58. Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism
    Bart D. van Rooijen, Mireille M. A. E. Claessens, Vinod Subramaniam · 2010 · PLoS ONE
  59. Molecular tweezers for lysine and arginine – powerful inhibitors of pathologic protein aggregation
    Thomas H. Schrader, Gal Bitan, Frank‐Gerrit Klärner · 2016 · Chemical Communications
  60. A polysaccharide from Polygonatum sibiricum attenuates amyloid-β-induced neurotoxicity in PC12 cells
    Huixue Zhang, Yuze Cao, Lixia Chen, Jianjian Wang, Qinghua Tian, Ning Wang, Zhaojun Liu, Jie Li, Na Wang, Xiaokun Wang et al. · 2014 · Carbohydrate Polymers
  61. Tau Oligomers Neurotoxicity
    Grażyna Niewiadomska, Wiktor Niewiadomski, Marta Steczkowska, Anna Gąsiorowska · 2021 · Life
  62. Metal exposure and Alzheimer’s pathogenesis
    Guijian Liu, Weidong Huang, Robert D. Moir, Charles R. Vanderburg, Barry Chi Hong Lai, Zicheng Peng, Rudolph E. Tanzi, Jack T. Rogers, Xudong Huang · 2006 · Journal of Structural Biology
  63. Structural Stability and Dynamics of an Amyloid-Forming Peptide GNNQQNY from the Yeast Prion Sup-35
    Jie Zheng, Buyong Ma, Chung‐Jung Tsai, Ruth Nussinov · 2006 · Biophysical Journal
  64. Gold nanoparticles: preparation, functionalisation and applications in biochemistry and immunochemistry
    Lev A. Dykman, Vladimir Aleksandrovich Bogatyrev · 2007 · Russian Chemical Reviews
  65. Structure–activity relationship of amyloid fibrils
    S. Maji, Lei Wang, J. Greenwald, R. Riek · 2009 · FEBS Letters
  66. Site-Specific Blockade of RAGE-VdPrevents Amyloid-β Oligomer Neurotoxicity
    Sturchler, Emmanuel, Galichet, Arnaud, Weibel, Mirjam, Leclerc, Estelle, Heizmann, Claus W. · 2008 · The Journal of Neuroscience
  67. Parenchymal and vascular Aβ‐deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease
    Thal, Dietmar Rudolf, Griffin, W. Sue T., Braak, Heiko · 2008 · Journal of Cellular and Molecular Medicine
  68. Extending the PRIME model for protein aggregation to all 20 amino acids
    Mookyung Cheon, Iksoo Chang, Carol K. Hall · 2010 · Proteins Structure Function and Bioinformatics
  69. p53 amyloid formation leading to its loss of function: implications in cancer pathogenesis
    Saikat Ghosh, Shimul Salot, Shinjinee Sengupta, Ambuja Navalkar, Dhiman Ghosh, Reeba Susan Jacob, Subhadeep Das, Rakesh Kumar, Narendra Nath Jha, Shruti Sahay et al. · 2017 · Cell Death and Differentiation
  70. Oxidative stress mediates the pathogenic effect of different Alzheimer’s disease risk factors
    Michela Guglielmotto · 2010 · Frontiers in Aging Neuroscience
  71. Role of molecular chaperones in neurodegenerative disorders
    Anatoli B. Meriin, Michael Y. Sherman · 2005 · International Journal of Hyperthermia
  72. Autophagy Dysfunction in Alzheimer’s Disease: Mechanistic Insights and New Therapeutic Opportunities
    Di Meco, Antonio, Curtis, Mary Elizabeth, Lauretti, Elisabetta, Praticò, Domenico · 2020 · Biological Psychiatry
  73. Visualizing and trapping transient oligomers in amyloid assembly pathways
    Emma E. Cawood, Theodoros K. Karamanos, Andrew John Wilson, Sheena E. Radford · 2020 · Biophysical Chemistry
  74. Increased soluble amyloid-β peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein
    Zerbinatti, Celina V., Wozniak, David F., Cirrito, John, Cam, Judy A., Osaka, Hiroshi, Bales, Kelly R., Zhuo, Min, Paul, Steven M., Holtzman, David M., Bu, Guojun · 2004 · Proceedings of the National Academy of Sciences
  75. Amyloid deposits: Protection against toxic protein species?
    Sebastian Treusch, Douglas Cyr, Susan Lee Lindquist · 2009 · Cell Cycle
  76. Evaluation of protease resistance and toxicity of amyloid-like food fibrils from whey, soy, kidney bean, and egg white
    Moritz Lassé, Dulantha Ulluwishewa, Jackie P. Healy, Dion R. Thompson, Antonia G. Miller, Nicole Clemence Roy, Kenny Chitcholtan, Juliet A. Gerrard · 2015 · Food Chemistry
  77. Detailed Analysis of the Energy Barriers for Amyloid Fibril Growth
    Alexander Kai Buell, Anne Dhulesia, Duncan A. White, Tuomas P. J. Knowles, Christopher Martin Dobson, Mark Edward Welland · 2012 · Angewandte Chemie International Edition
  78. Formation and Toxicity of Soluble Polyglutamine Oligomers in Living Cells
    Patrick Lajoie, Erik L. Snapp · 2010 · PLoS ONE
  79. Characterizing the conformational ensemble of monomeric polyglutamine
    Xiao-Ling Wang, Andreas Vitalis, Matthew A. Wyczalkowski, Rohit V. Pappu · 2005 · Proteins Structure Function and Bioinformatics
  80. Biological and medical physics, biomedical engineering
    Irving P. Herman · 2014
  81. Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease
    Lifan Zhang, Xiaolin Yu, Mei Ji, Shuying Liu, Xingyu Wu, Yujiong Wang, Rui‐tian Liu · 2018 · Food & Function
  82. The systemic amyloidoses
    Joel N. Buxbaum · 2003 · Current Opinion in Rheumatology
  83. Potential implications of endogenous aldehydes in β‐amyloid misfolding, oligomerization and fibrillogenesis
    Chen, Kun, Maley, Jason, Yu, Peter H. · 2006 · Journal of Neurochemistry
  84. Amyloids: From molecular structure to mechanical properties
    Michael Schleeger, Corianne C. vandenAkker, Tanja Deckert‐Gaudig, Volker Deckert, Krassimir P. Velikov, Gijsje Hendrika Koenderink, Mischa Bonn · 2013 · Polymer
  85. Conserved features of intermediates in amyloid assembly determine their benign or toxic states
    Rajaraman Krishnan, Jessica L. Goodman, Samrat Mukhopadhyay, Chris D. Pacheco, Edward A. Lemke, Ashok A. Deniz, Susan Lee Lindquist · 2012 · Proceedings of the National Academy of Sciences
  86. Alzheimer's disease: insights from Drosophila melanogaster models
    Aileen M. Moloney, David Barry Sattelle, David A. Lomas, Damian C. Crowther · 2009 · Trends in Biochemical Sciences
  87. p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis
    Qiu‐Lan Ma, Fusheng Yang, Frédéric Calon, Oliver J. Ubeda, James E. Hansen, Richard H. Weisbart, Walter K. Beech, Sally Ann Frautschy, Greg M. Cole · 2008 · Journal of Biological Chemistry
  88. Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases
    Dillon J. Rinauro, Fabrizio Chiti, Michele Vendruscolo, Ryan Limbocker · 2024 · Molecular Neurodegeneration
  89. α-Synuclein and Neuronal Cell Death
    Toru Yasuda, Yasuto Nakata, Hideki Mochizuki · 2012 · Molecular Neurobiology
  90. Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer’s disease
    Pujadas, Lluís, Rossi, Daniela, Andrés, Rosa, Teixeira, Cátia M., Serra-Vidal, Bernat, Parcerisas, Antoni, Maldonado, Rafael, Giralt, Ernest, Carulla, Natàlia, Soriano, Eduardo · 2014 · Nature Communications
  91. The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties
    Thomas Näsström, Therese Fagerqvist, Mikael Barbu, Mikael Karlsson, Fredrik K. Nikolajeff, Alex Kasrayan, Monica Ekberg, Lars Lannfelt, Martin Ingelsson, Joakim J. E. Bergström · 2010 · Free Radical Biology and Medicine
  92. Sequestration of a β‐Hairpin for Control of α‐Synuclein Aggregation
    Ewa A. Mirecka, Hamed Shaykhalishahi, Aziz Gauhar, Şerife Akgül, Justin Lecher, Dieter Willbold, Matthias Stoldt, Wolfgang Hoyer · 2014 · Angewandte Chemie International Edition
  93. Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1ΔE9 Mice
    Iliya M. Lefterov, Nicholas Francis Fitz, Andrea A. Cronican, Allison Fogg, Preslav Lefterov, Ravindra B. Kodali, Ronald B. Wetzel, Radosveta P. Koldamova · 2010 · Journal of Biological Chemistry
  94. Membrane permeabilization by Islet Amyloid Polypeptide
    Maarten F. M. Engel · 2009 · Chemistry and Physics of Lipids
  95. Defining α-synuclein species responsible for Parkinson’s disease phenotypes in mice
    Froula, Jessica M., Castellana-Cruz, Marta, Anabtawi, Nadia M., Camino, José D., Chen, Serene W., Thrasher, Drake R., Freire, Jennifer, Yazdi, Allen A., Fleming, Sheila, Dobson, Christopher M. et al. · 2019 · Journal of Biological Chemistry
  96. Down syndrome and beta-amyloid deposition
    Elizabeth Head, Ira T. Lott · 2004 · Current Opinion in Neurology
  97. Physicochemical characteristics of soluble oligomeric Aβand their pathologic role in Alzheimer's disease
    Desiree Watson, Eduardo Castaño, Tyler A. Kokjohn, Yu‐Min Kuo, Yuri L. Lyubchenko, David J. Pinsky, Edward Sander Connolly, Chera L. Esh, Dean C. Luehrs, W. Blaine Stine et al. · 2005 · Neurological Research
  98. Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type Huntingtin
    Anne Busch, Sabine Engemann, Rudi Lurz, Hitoshi Okazawa, Hans Lehrach, Erich E. Wanker · 2003 · Journal of Biological Chemistry
  99. In Silico Assembly of Alzheimer's Aβ16-22 Peptide into β-Sheets
    Sébastien Santini, Normand Mousseau, Philippe Derreumaux · 2004 · Journal of the American Chemical Society
  100. Evidence of the Existence of Micelles in the Fibrillogenesis of β-Amyloid Peptide
    Raimon Sabaté, Joan Estelrich · 2005 · The Journal of Physical Chemistry B